Identifying Mixed Phenotype: Evaluating the Presence of Polyneuropathy in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Cardiomyopathy

被引：0
|
作者：
Merkel, Madeline [1 ]
Grogan, Martha [2 ]
Hawkins, Philip N. [3 ]
Kristen, Arnt V. [4 ]
Berk, John L. [5 ]
Suhr, Ole B. [6 ]
Lin, Hollis [1 ]
McManus, Anastasia [1 ]
Powell, Christine [1 ]
Vest, John [1 ]
Karsten, Verena [1 ]
Judge, Daniel P. [7 ]
机构：
[1] Alnylam Pharmaceut, Cambridge, MA USA
[2] Mayo Clin, Rochester, MN USA
[3] Royal Free Hosp, NAC, London, England
[4] Heidelberg Univ Hosp, Heidelberg, Germany
[5] Boston Univ, Boston, MA 02215 USA
[6] Umea Univ, Umea, Sweden
[7] Med Univ South Carolina, Columbia, SC USA
来源：
NEUROLOGY | 2020年 / 94卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
240
引用
收藏
页数：4
相关论文
共 50 条
  • [21] LONG-TERM, INTEGRATED CARDIAC SAFETY OF PATISIRAN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH POLYNEUROPATHY
    Dispenzieri, Angela
    Gillmore, Julian
    Polydefkis, Michael
    Plante-Bordeneuve, Violaine
    Schmidt, Hartmut
    Berber, Erhan
    Wang, Jing Jing
    Sweetser, Marianne
    White, Matthew
    Maurer, Mathew
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 690 - 690
  • [22] Patisiran for the Treatment of Transthyretin-mediated Amyloidosis with Cardiomyopathy
    Ioannou, Adam
    Fontana, Marianna
    Gillmore, Julian D.
    HEART INTERNATIONAL, 2023, 17 (01): : 27 - 35
  • [23] EFFECT OF RNAI ON CARDIOMYOPATHY AND POLYNEUROPATHY OUTCOMES IN PATIENTS WITH V122I VARIANT HEREDITARY TRANSTHYRETIN-MEDIATED (HATTR OR ATTRV) AMYLOIDOSIS
    Sperry, Brett Wesley
    Quan, Dianna
    Mauricio, Elizabeth
    Small, Roy S.
    Ananthasubramaniam, Karthikeyan
    Egolum, Ugochukwu Onyibo
    Roblin, Steven
    Yureneva, Elena
    Chou, Lin-Na
    Jay, Patrick
    Capocelli, Kelley
    Freimer, Miriam
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 343 - 343
  • [24] Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)
    Daniel P. Judge
    Arnt V. Kristen
    Martha Grogan
    Mathew S. Maurer
    Rodney H. Falk
    Mazen Hanna
    Julian Gillmore
    Pushkal Garg
    Akshay K. Vaishnaw
    Jamie Harrop
    Christine Powell
    Verena Karsten
    Xiaoping Zhang
    Marianne T. Sweetser
    John Vest
    Philip N. Hawkins
    Cardiovascular Drugs and Therapy, 2020, 34 : 357 - 370
  • [25] Evaluation of methodologies for indirect comparison of eplontersen and vutrisiran for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy
    Karam, Chafic
    Gillmore, Julian
    Chen, Gengshi
    Jenkins, Nia
    Hale, Mike
    Taylor, Gemma
    Chen, Jersey
    Viney, Nicholas
    Schneider, Eugene
    NEUROLOGY, 2023, 100 (17)
  • [26] An indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy
    Plante-Bordeneuve, Violaine
    Lin, Hollis
    Gollob, Jared
    Agarwal, Sonalee
    Betts, Marissa
    Fahrbach, Kyle
    Chitnis, Madhura
    Polydefkis, Michael
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (04) : 473 - 481
  • [27] Effectiveness of patisiran after switching from tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy
    Labeyrie, Celine
    Merkel, Madeline
    Sethi, Sakshi
    Popadic, Lyuba
    Yang, Hongbo
    Sweetser, Marianne T.
    Lin, Hollis
    Adams, David
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (09)
  • [28] Hereditary transthyretin-mediated amyloidosis with polyneuropathy: baseline anthropometric, demographic and disease characteristics of patients from a reference center
    Cunha Sequeira, Vanessa Cristina
    Penetra, Maria Alice
    Duarte, Lisa
    de Azevedo, Fernanda Reis
    Santa Rosa Sayegh, Raphael
    Pedrosa, Roberto Coury
    Cruz, Marcia Waddington
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2022, 80 (03) : 262 - 269
  • [29] HELIOS-A: RESULTS FROM THE PHASE 3 STUDY OF VUTRISIRAN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH POLYNEUROPATHY
    Gonzalez-Duarte, Alejandra
    Adams, David
    Tournev, Ivailo
    Taylor, Mark
    Coelho, Teresa
    Plante-Bordeneuve, Violaine
    Berk, John
    Gillmore, Julian David
    Low, Soon-Chai
    Sekijima, Yoshiki
    Obici, Laura
    Chen, Chongshu
    Badri, Prajakta
    Arum, Seth
    Vest, John
    Polydefkis, Michael
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 302 - 302
  • [30] Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)
    Judge, Daniel P.
    Kristen, Arnt V.
    Grogan, Martha
    Maurer, Mathew S.
    Falk, Rodney H.
    Hanna, Mazen
    Gillmore, Julian
    Garg, Pushkal
    Vaishnaw, Akshay K.
    Harrop, Jamie
    Powell, Christine
    Karsten, Verena
    Zhang, Xiaoping
    Sweetser, Marianne T.
    Vest, John
    Hawkins, Philip N.
    CARDIOVASCULAR DRUGS AND THERAPY, 2020, 34 (03) : 357 - 370
12345